New onset refractory status epilepticus: Summary of the NORSE Institute roundtable during the 2023 American Epilepsy Society meeting, Orlando, Florida-Reference-Cited by-同舟云学术

New onset refractory status epilepticus: Summary of the NORSE Institute roundtable during the 2023 American Epilepsy Society meeting, Orlando, Florida

Published:2024-02-29 Issue:4 Volume:65 Page:1145-1146
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Hanin Aurélie¹²³^ORCID,Eschbach Krista⁴^ORCID,Gofton Teneille E.⁵^ORCID,Gopaul Margaret¹,Howe Charles L.⁶^ORCID,Lai Yi‐Chen⁷^ORCID,Koh Sookyong⁸,Shen Haying⁸,Hirsch Lawrence J.¹^ORCID

Affiliation:

1. Department of Neurology, Comprehensive Epilepsy Center Yale University School of Medicine New Haven Connecticut USA

2. Sorbonne Université, Institut du Cerveau, Paris Brain Institute, ICM, Inserm, CNRS, AP‐HP, Hôpital de la Pitié‐Salpêtrière Paris France

3. Assistance Publique ‐ Hôpitaux de Paris, Hôpital de la Pitié‐Salpêtrière, DMU Neurosciences, Epilepsy Unit and Department of Clinical Neurophysiology Paris France

4. Department of Pediatrics, Section of Neurology University of Colorado School of Medicine, Children's Hospital Colorado Aurora Colorado USA

5. University Hospital London Health Sciences Center London Ontario Canada

6. Department of Neurology Mayo Clinic Rochester Minnesota USA

7. Baylor College of Medicine Texas Children's Hospital Houston Texas USA

8. Children's Hospital and Medical Center, Department of Pediatrics University of Nebraska Omaha Nebraska USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.17934

Reference9 articles.

1. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions

2. Cytokines in New‐Onset Refractory Status Epilepticus Predict Outcomes

3. An in vitro model of drug-resistant seizures for selecting clinically effective antiseizure medications in Febrile Infection-Related Epilepsy Syndrome

4. Drug‐resistant seizures associated with hyperinflammatory monocytes in FIRES

5. Interleukin-1 in Febrile Infection-Related Epilepsy Syndrome